Johnson & Johnson said it has settled most of the lawsuits it faced from thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in connection with the agreement. J&J said in a filing with the U.S. Securities and Exchange Commission on Friday that it…

Etzler Lawhead Legal Group, PCNovember 8, 2021